Apr 2, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-4615-0009
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2018-D-4615: Content and Format of Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry.